As of October 1st 2024, Evidence Prime has been awarded a grant under the Polish Agency for Enterprise Development (PARP) SMART Path program, part of the European Funds for a Modern Economy Programme (FENG) initiative. The overall aim of the grant is to help businesses improve innovation, adopt sustainable and digital practices, expand globally, upgrade research facilities, and develop employee skills.
What is the SMART Path Program?
The SMART Path program provides funding for various activities such as research and development (R&D) and internationalization. The program aims to support companies like Evidence Prime to pursue projects that align with global trends in innovation and sustainability.
In the latest round, PARP received over 2,700 funding applications, of which only 201 projects were positively assessed and selected for co-financing. With approximately PLN 1.4 billion (300 mln EUR) allocated, this initiative is set to drive innovation across Poland, and we are proud to be part of it.
Based on the ranking list analysis, only 8% of projects were approved (201 out of 2,641), and our project is in the top 5% regarding grant value (11th out of 201).
Our Vision for the Future
We are honored to be awarded this grant and committed to meeting and potentially exceeding expectations. We look forward to what we can contribute to evidence-based decision-making.
With this grant, we aim to:
- Expand automation capabilities: With additional resources, we plan to create and enhance our AI-driven models.
- Drive digital transformation: Through innovation in several crucial areas, from accessibility for those with disabilities to improving contextualized model operations.
- Expand our international reach: With support for internationalization, we plan to broaden our global presence and collaborate with more organizations worldwide.
What This Means for Our Customers
For our clients and partners, this grant means that Evidence Prime will continue to develop solutions that make the evidence synthesis process more efficient, accessible, and impactful. The SMART path program's funding will allow us to improve our existing products further and explore new possibilities in research, AI, and digital transformation.
This grant strengthens our mission to advance the decision-making processes in healthcare and beyond, and we look forward to sharing our results in the upcoming months.
About Laser AI
Laser AI, one of our products, simplifies systematic literature reviews, making them faster, more accurate, and accessible to professionals across various industries. Our commitment to innovation and excellence will have us constantly looking at how we can improve how evidence is synthesised and used globally.